Antifungal plant defensin technology platform.
Safe and effective application of the plant defensin technology to the treatment of human fungal disease.
Share price, ASX announcements and investor resources.
Recently WILSONS published its initiation research report on Hexima Limited (ASX:HXL) with an OVERWEIGHT rating and a $0.75 12-month price target.
View the full report (pdf)